On August 26, the HICOOL 2026 Global Entrepreneur Summit opened at the China International Exhibition Center (Shunyi Venue) in Beijing. Under the theme “From the Source of Innovation to the Forefront of Industry,” this summit has been extended to four days for the first time and is expected to attract over 50,000 visits from global innovators. ZGC Capital, a subsidiary of ZGC Group, made an impressive appearance alongside more than ten of its invested enterprises, including BeOne Medicines, InnoCare Pharma, Migrasome, LiblibAI, Zoellent Technology, and MultiFields Technology. They showcased innovative achievements in frontier fields such as biopharmaceuticals and healthcare, artificial intelligence, and new materials, highlighting the ecological power of patient capital in empowering sci-tech innovation.

The summit reached a new scale, attracting 10,209 entrepreneurial projects and 13,472 entrepreneurs from 141 countries and regions worldwide. The summit features five exhibition areas: HICOOL’s Contribution to Beijing’s High-Quality Development Pavilion, the Innovation and Entrepreneurship Pavilion, the World-Class Universities Pavilion, the International Partners and Startups Pavilion, and the Venture Capital Pavilion. These areas have gathered over 600 exhibitors, more than 300 entrepreneurial projects, and over 300 investment institutions. ZGC Capital’s booth was located in a prime position within the Venture Capital Pavilion, comprehensively displaying the fruitful achievements of ZGC Group and ZGC Capital in serving sci-tech innovation and entrepreneurship.